Portfolio company
BioAge Labs
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Centenara Labs
This company develops and invests in therapeutics targeting age-related diseases for patients needing extended healthspan and improved lifespan.
Integrated Biosciences
The company develops small-molecule therapies for age-related diseases using a synthetic biology and machine learning platform to target cellular stress responses.
ImmuneAGE
This company develops a drug discovery platform for creating therapies that rejuvenate the immune system by targeting hematopoietic stem cells in the bone marrow.
Cambrian Biopharma
The company develops therapeutics targeting biological drivers of aging and chronic diseases for pharmaceutical partners, healthcare providers and patients.
Gordian Biotechnology
This company develops an in vivo drug discovery platform to identify therapies for age-related diseases for the pharmaceutical and healthcare sectors.
clock.bio
This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.
Shift Bioscience
This biotechnology company develops cellular rejuvenation therapeutics and an AI-driven discovery platform for pharmaceutical researchers to treat age-related diseases.
Compound Life
This company develops a biomarker profiling and health tracking platform for individuals seeking to monitor their healthspan and biological age.
